4.3 Article

SILCS diaphragm: postcoital testing of a new single-size contraceptive device

Journal

CONTRACEPTION
Volume 78, Issue 3, Pages 237-244

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.contraception.2008.04.118

Keywords

diaphragm; postcoital test; SILCS; nonoxynol-9

Funding

  1. CONRAD
  2. National Institutes of Health General Clinic Research Center [M01RR000056]

Ask authors/readers for more resources

Background: This study was conducted to compare the effectiveness of a new, single-size silicone contraceptive diaphragm used with either spermicide 12% nonoxynol-9 (N-9)] or lubricant ill preventing sperm from penetrating midcycle cervical mucus. Study design: A crossover postcoital test (PCT) in healthy, Sexually active women not at risk for pregnancy due to tubal occlusion was conducted, Couples had a baseline PCT without a device to verify normal fertility parameters. Qualified Couples underwent Up to two test Cycles using the SILCS diaphragm with a metal spring. A subgroup Of Couples underwent a third test cycle with the SILCS polymer spring diaphragm used with N-9 gel. Results: Fifteen couples completed a baseline cycle and were randomized to order of study gel. Of these 14 couples completed a baseline cycle and at least one test cycle, 12 couples completed a baseline cycle and two test cycles and S couples completed a third test cycle with file polymer spring prototype. Sperm was detected ill the vaginal pool ill all completed test cycles, The SILCS Metal Spring diaphragms used With N-9 gel reduced the average number of progressively motile sperm per high power field in the cervical mucus from a baseline of 12.5 to 0, while use of this device with lubricant reduced the number to 0.5. The SILCS polymer spring diaphragm used with N-9 performed the same as the metal spring used with N-9 Conclusion: The SILCS diaphragm used with N-9 gel performed well. It is likely that the SILCS diaphragm will give acceptable results in a contraceptive effectiveness study but that adjunctive use of a chemical barrier such as N-9 gel will be necessary for it to be most effective. (C) 2008 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Obstetrics & Gynecology

Conception rates in women desiring pregnancy after levonorgestrel 52 mg intrauterine system (Liletta®) discontinuation

Bruce R. Carr, Michael A. Thomas, Angelina Gangestad, David L. Eisenberg, Andrea Olariu, Mitchell D. Creinin

Summary: The study evaluated reproductive function in nulligravid and gravid women after discontinuation of the levonorgestrel 52 mg intrauterine system (IUS). It found that women had rapid return of fertility in the year post-removal, with fertility rates not varying based on gravidity, parity, age at discontinuation, or duration of IUS use.

CONTRACEPTION (2021)

Article Obstetrics & Gynecology

Twelve-month prescribing of contraceptive pill, patch, and ring before and after a standardized electronic medical record order change

Suji Uhm, Melissa J. Chen, Erika D. Cutler, Mitchell D. Creinin

Summary: After changing the default dispensing quantity in electronic medical record orders from one month to 12 months, providers prescribed a 12-month supply of contraceptive pills, patches, and rings more frequently. Providers at the medical center campus increased 12-month prescriptions after the change, while non-obstetrics/gynecology providers at community clinics also increased 12-month prescriptions, but obstetrics/gynecology providers did not.

CONTRACEPTION (2021)

Editorial Material Obstetrics & Gynecology

Coronavirus disease 2019 impact on abortion care at a Northern California tertiary family planning program

Mitchell D. Creinin, Hailee Tougas, Machelle Wilson, Melissa C. Matulich

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)

Article Obstetrics & Gynecology

Relationship of parity and prior cesarean delivery to levonorgestrel 52 mg intrauterine system expulsion over 6 years

Melissa L. Gilliam, Jeffrey T. Jensen, David L. Eisenberg, Michael A. Thomas, Andrea Olariu, Mitchell D. Creinin

Summary: This study aimed to assess the relationship between parity and prior route of delivery to levonorgestrel 52 mg intrauterine system expulsion. Results showed that IUS expulsion occurs in less than 4% of users over the first 6 years of use, mostly during the first year, and is more likely among obese and parous women.

CONTRACEPTION (2021)

Article Obstetrics & Gynecology

Standardizing abortion research outcomes (STAR): Results from an international consensus development study

Katherine C. Whitehouse, Bianca M. Stifani, James M. N. Duffy, Caron R. Kim, Mitchell D. Creinin, Teresa DePineres, Beverly Winikoff, Kristina Gemzell-Danielsson, Jennifer Blum, Renee Bracey Sherman, Antonella F. Lavelanet, Dalia Brahmi, Daniel Grossman, Anand Tamang, Hailemichael Gebreselassie, Rodolfo Gomez Ponce de Leon, Bela Ganatra

Summary: By using consensus methods, a core outcome set for future abortion research has been developed, consisting of 15 outcomes that can standardize research, decrease trial heterogeneity, and enhance the quality of systematic reviews and clinical guidelines. Researchers are encouraged to select, collect, and report these core outcomes in future abortion trials, while journal editors should promote the reporting of core outcome sets.

CONTRACEPTION (2021)

Article Obstetrics & Gynecology

Mifepristone prior to osmotic dilators for dilation and evacuation cervical preparation: A randomized, double-blind, placebo-controlled pilot study

Suji Uhm, Namrata Mastey, Courtney C. Baker, Melissa J. Chen, Melissa C. Matulich, Melody Y. Hou, Juliana Melo, Susan F. Wilson, Mitchell D. Creinin

Summary: This study aimed to evaluate the impact of mifepristone given 18 to 24 hours before osmotic dilator placement on procedural outcomes. The results showed that mifepristone increased the initial cervical dilation but did not significantly affect the proportion of participants requiring additional dilators. The subjective perception of the procedure and complication rates were similar between the mifepristone and placebo groups.

CONTRACEPTION (2022)

Article Pharmacology & Pharmacy

Pharmacists' knowledge, perspectives, and experiences with mifepristone dispensing for medication abortion

Shelly Kaller, Natalie Morris, M. Antonia Biggs, C. Finley Baba, Sally Ra, Tina R. Raine-Bennett, Mitchell D. Creinin, Erin Berry, Elizabeth A. Micks, Karen R. Meckstroth, Sarah Averbach, Daniel Grossman

Summary: The study aimed to assess the feasibility of pharmacists dispensing mifepristone. Results showed that most pharmacists were willing to be trained, dispensed mifepristone with few challenges, were satisfied with the model, and had higher knowledge levels at follow-up.

JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION (2021)

Article Health Care Sciences & Services

Assessing the Pregnancy Protective Impact of Scheduled Nonadherence to a Novel Progestin-Only Pill: Protocol for a Prospective, Multicenter, Randomized, Crossover Study

Alison Edelman, Agnes Hemon, Mitchell Creinin, Pascale Borensztein, Bruno Scherrer, Anna Glasier

Summary: This study aims to determine the cervical mucus characteristics following a 6-hour delayed pill intake or after one missed pill compared to typical daily use of norgestrel 75 mcg. The study has successfully enrolled 52 subjects and the analysis of the results is pending. The protocol was approved by a central review board and the study procedures were executed successfully.

JMIR RESEARCH PROTOCOLS (2021)

Editorial Material Obstetrics & Gynecology

Society of Family Planning Committee statement on IUD nomenclature Comment

Mitchell Creinin, Julia E. Kohn, Jennifer H. Tang, Tania Basu Serna

CONTRACEPTION (2022)

Article Obstetrics & Gynecology

Levonorgestrel 52 mg intrauterine system efficacy and safety through 8 years of use

Mitchell D. Creinin, Courtney A. Schreiber, David K. Turok, Carrie Cwiak, Beatrice A. Chen, Andrea Olariu

Summary: This study aimed to evaluate the efficacy and safety of the levonorgestrel 52 mg intrauterine system during years 7 and 8 of use. The results showed that the system is highly effective and safe over an 8-year period of use, with low pregnancy rates and high user satisfaction.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)

Article Obstetrics & Gynecology

Contraceptive plans before preoperative assessment and at procedure in surgical abortion patients

Britany R. Lundberg, Angel Tabuyo-Martin, Matthew D. Ponzini, Machelle D. Wilson, Mitchell D. Creinin

Summary: This study investigated changes in contraceptive method plans before, during, and after abortion among patients. The results showed that most patients received the method they initially identified at the telephone intake, especially those planning to use an IUD or implant. Undecided patients were open to discussing various options.

CONTRACEPTION (2022)

Editorial Material Obstetrics & Gynecology

Recommendations for standardization of bleeding data analyses in contraceptive studies Comment

Mitchell D. Creinin, Carolina Sales Vieira, Carolyn L. Westhoff, Diana J. A. Mansour

Summary: This study aims to address limitations in existing definitions of menstrual bleeding changes associated with contraceptive methods and proposes new recommendations for standardized bleeding data analyses. The study suggests three criteria for assessing bleeding outcomes: pattern, flow, and duration, and provides descriptors for each criterion based on the predictability of bleeding patterns. Standardizing outcomes allows for better comparison between studies and improved understanding of differences between contraceptive products for both clinicians and patients.

CONTRACEPTION (2022)

Letter Health Care Sciences & Services

Comparing IUC and Tubal Ligation

Mitchell D. Creinin, Melody Y. Hou

JOURNAL OF GENERAL INTERNAL MEDICINE (2023)

Article Obstetrics & Gynecology

Clinical interventions are more accurate than quantitative measurements for defining hemorrhage with dilation and evacuation

Cassandra M. Gilbert, Melissa C. Matulich, Matthew D. Ponzini, Machelle D. Wilson, Mitchell D. Creinin

Summary: This study aimed to assess the correlation between quantitative blood loss (QBL) and clinically relevant outcomes or hemorrhage in dilation and evacuation (D&E) procedures. The findings showed that the majority of patients (75%) with clinically relevant bleeding outcomes had a QBL of 500mL or less. Therefore, the need for clinical interventions should be used to define hemorrhage in D&E procedures, rather than a specific amount of blood loss.

CONTRACEPTION (2023)

Letter Obstetrics & Gynecology

Extending use of levonorgestrel 52 mg intrauterine device to 8 years

Mitchell D. Creinin, Jeffrey T. Jensen

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2023)

No Data Available